Literature DB >> 26221375

Association analysis of genetic variants of adiponectin gene and risk of pancreatic cancer.

Jian-Ping Yang1, Xin Li2, Feng Wang2, Ming Gao2, Sheng-Lei Li1, Kui-Sheng Chen1.   

Abstract

Adiponectin is a cytokine exclusively secreted from adipocyte, and could perform direct or indirect effects on anti-inflammation and anti-tumor. Previous researches have studied the correlation between plasma adiponectin levels and the risk of pancreatic cancer. So we aimed at investigating the association of genetic variants of adiponectin gene and the risk of pancreatic cancer. In this study, we genotyped 6 SNPs of adiponectin gene in a case-control study of recruited 172 patients of pancreatic cancer and 181 healthy people in Chinese Han population. The results indicated that two of the SNPs had significant associations with pancreatic cancer. Of which, the SNP rs1501299C>A decreased the risk of PC (P=0.016, OR=0.662 95% CI 0.472-0.928), while rs1065358T>C increased the risk of PC (P=0.027, OR=1.421 95% CI 1.040-1.941). Furthermore, in the clinical correlation analysis, we found rs1501299 was correlated with tumor size (P=0.026), cigarette smoking (P=0.022) and alcohol consumption (P=0.001) and rs1063538 was correlated with alcohol consumption (P=0.026). In conclusion, we provided evidences that the variants in adiponectin gene might influence the development and progression of pancreatic cancer.

Entities:  

Keywords:  Adiponectin gene; pancreatic cancer; single nucleotide polymorphism

Year:  2015        PMID: 26221375      PMCID: PMC4509320     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

Review 1.  The epidemiology of pancreatitis and pancreatic cancer.

Authors:  Dhiraj Yadav; Albert B Lowenfels
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

2.  Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.

Authors:  Preet K Dhillon; Kathryn L Penney; Fredrick Schumacher; Jennifer R Rider; Howard D Sesso; Michael Pollak; Michelangelo Fiorentino; Stephen Finn; Massimo Loda; Nader Rifai; Lorelei A Mucci; Edward Giovannucci; Meir J Stampfer; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

3.  The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.

Authors:  Verena A Grote; Sabine Rohrmann; Laure Dossus; Alexandra Nieters; Jytte Halkjaer; Anne Tjønneland; Kim Overvad; Jakob Stegger; Nathalie Chabbert-Buffet; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Birgit Teucher; Susen Becker; Jukka Montonen; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; Amalia Mattiello; Marcial Argüelles; Eric J Duell; Esther Molina-Montes; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte Gurrea; Suzanne M Jeurnink; Petra Hm Peeters; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Francesca L Crowe; Isabelle Romieu; Sabina Rinaldi; Mazda Jenab; Dora Romaguera; Dominique S Michaud; Elio Riboli; H Bas Bueno-de-Mesquita; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2011-09-17       Impact factor: 7.396

Review 4.  The molecular genetics of pancreatic ductal carcinoma.

Authors:  T A Sohn
Journal:  Minerva Chir       Date:  2002-10       Impact factor: 1.000

5.  Plasma adiponectin and gastric cancer.

Authors:  Makoto Ishikawa; Joji Kitayama; Shinsuke Kazama; Takeyuki Hiramatsu; Kenji Hatano; Hirokazu Nagawa
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

6.  Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.

Authors:  Neeraj K Saxena; Ping P Fu; Arumugam Nagalingam; Jason Wang; Jeffrey Handy; Cynthia Cohen; Mourad Tighiouart; Dipali Sharma; Frank A Anania
Journal:  Gastroenterology       Date:  2010-07-13       Impact factor: 22.682

7.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

8.  Cancer in first and second generation Americans.

Authors:  D B Thomas; M R Karagas
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

9.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer.

Authors:  Li Liu; Rong Zhong; Sheng Wei; Jie-Yun Yin; Hao Xiang; Li Zou; Wei Chen; Ji-Gui Chen; Xia-Wen Zheng; Li-Juan Huang; Bei-Bei Zhu; Quan Chen; Sheng-Yu Duan; Rui Rui; Bei-Fang Yang; Jing-Wen Sun; Duo-Shuang Xie; Yi-Hua Xu; Xiao-Ping Miao; Shao-Fa Nie
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

View more
  5 in total

Review 1.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

2.  ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer.

Authors:  Rosa Divella; Antonella Daniele; Antonio Mazzocca; Ines Abbate; Porzia Casamassima; Cosimo Caliandro; Eustachio Ruggeri; Emanuele Naglieri; Carlo Sabbà; Raffaele De Luca
Journal:  J Cancer       Date:  2017-03-25       Impact factor: 4.207

Review 3.  Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.

Authors:  Ramesh Pothuraju; Satyanarayana Rachagani; Wade M Junker; Sanjib Chaudhary; Viswanathan Saraswathi; Sukhwinder Kaur; Surinder K Batra
Journal:  J Exp Clin Cancer Res       Date:  2018-12-19

4.  AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?

Authors:  Luigi Sapio; Angela Ragone; Annamaria Spina; Alessia Salzillo; Silvio Naviglio
Journal:  Cancer Drug Resist       Date:  2022-06-21

Review 5.  Role of the microbiome in occurrence, development and treatment of pancreatic cancer.

Authors:  Yicheng Wang; Gang Yang; Lei You; Jinshou Yang; Mengyu Feng; Jiangdong Qiu; Fangyu Zhao; Yueze Liu; Zhe Cao; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2019-12-01       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.